Literature DB >> 7061711

Enzyme-linked immunosorbent assay for the diagnosis of recent rubella infection.

Y S Lim, C C Lam, S K Lam.   

Abstract

This paper presents further evidence of the sensitivity and reproducibility of ELISA for the detection of rubella antibody. This test can also be extended to include the diagnosis of recent rubella infections once the index of significance has been computed based on the estimated ELISA ratio of absorbance between the acute and convalescent serum samples. There is a greater than 90% agreement when compared to the results obtained by the haemagglutination-inhibition test. It should be further evaluated for rubella using purified rubella antigen to increase sensitivity and reproducibility.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061711      PMCID: PMC497455          DOI: 10.1136/jcp.35.1.101

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  A comparison of three tests for rubella antibody screening.

Authors:  P Morgan-Capner; H J Pullen; J R Pattison; D E Bidwell; A Bartlett; A Voller
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

2.  Enzyme-linked immunosorbent assay for determination of rubella IgG antibodies.

Authors:  M Vejtorp
Journal:  Acta Pathol Microbiol Scand B       Date:  1978-12

3.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

4.  A simple method for detecting antibodies to rubella.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1975-08

5.  The seroepidemiology of rubella in Kuala Lumpur, West Malaysia.

Authors:  S K Lam
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

6.  Antigen requirements, sensitivity, and specificity of enzyme immunoassays for measles and rubella viral antibodies.

Authors:  B Forghani; N J Schmidt
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.